Static Chart BriaCell Therapeutics Corp. Nasdaq

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-25 EDT			5-day change	1st Jan Change
4.315 ^USD	+0.82%		+2.49%	-39.31%

09-14	BriaCell Therapeutics Corp Receives Seventh Consecutive Positive DSMB Recommendation For Pivotal Phase 3 Bria-ABC Study Of Bria-IMT Plus Immune Checkpoint Inhibitor	CI
09-11	Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer	CI

Duration

Period